Perceive Biotherapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Perceive Biotherapeutics's estimated annual revenue is currently $1.5M per year.
- Perceive Biotherapeutics's estimated revenue per employee is $83,750
- Perceive Biotherapeutics's total funding is $117M.
Employee Data
- Perceive Biotherapeutics has 18 Employees.
- Perceive Biotherapeutics grew their employee count by 20% last year.
Perceive Biotherapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
2 | Chief Medical Officer | Reveal Email/Phone |
3 | Chief Technical Officer | Reveal Email/Phone |
4 | Chief Research Officer | Reveal Email/Phone |
5 | Chief Financial Officer | Reveal Email/Phone |
6 | Head Clinical Operations (Executive Director) | Reveal Email/Phone |
7 | Senior Director, Gene Therapy R&D and CMC | Reveal Email/Phone |
8 | Director Development | Reveal Email/Phone |
9 | Senior Scientist, Manager, Analytical Development | Reveal Email/Phone |
10 | Principal Scientist | Reveal Email/Phone |
Perceive Biotherapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $84.8M | 422 | 24% | N/A | N/A |
#2 | $0.4M | 2 | 0% | N/A | N/A |
#3 | $32M | 159 | 3% | N/A | N/A |
#4 | $35M | 121 | 3% | $62.5M | N/A |
#5 | $30.2M | 150 | 18% | N/A | N/A |
#6 | $135.3M | 542 | -3% | N/A | N/A |
#7 | $110.3M | 549 | N/A | N/A | N/A |
#8 | $60.1M | 299 | -4% | N/A | N/A |
#9 | $554.8M | 1634 | -2% | N/A | N/A |
#10 | $10.5M | 48 | 12% | N/A | N/A |
What Is Perceive Biotherapeutics?
A start-up developing novel ophthalmic therapeutics to treat major unmet needs for patients.
keywords:N/A$117M
Total Funding
18
Number of Employees
$1.5M
Revenue (est)
20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.6M | 18 | -14% | $69.1M |
#2 | $3.1M | 18 | -5% | N/A |
#3 | $4.3M | 18 | -5% | N/A |
#4 | $1.3M | 18 | -5% | $361.5M |
#5 | $0.5M | 18 | -10% | N/A |